Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409952 · ClinicalTrials.gov registry record · NA
Lutronic LaseMD for Treatment of Benign Pigmented Lesions
A NA study, sponsored by CynosureLutronic.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03409952: Completed NA study, sponsored by CynosureLutronic.
NCT03409952 is a NA study that has completed, run by CynosureLutronic. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03409952, a NA study, has completed, sponsored by CynosureLutronic.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The Lutronic LaseMD Laser System will be evaluated for the treatment of benign pigmented lesions.
Primary Outcome
Blinded assessment of paired post-treatment study photographs conducted by three blinded physician evaluators will compare split-side post-treatment photos. Each assessor will be given identical paired post-treatment photo sets. Each photo's treatment device (LaseMD or DUAL 1927nm) will NOT be marked. Each assessor will compare the Left and Right photo for improvement in benign pigmented lesions using the following definitions: Change = an improvement that is striking, substantial and immediate
Interventions
- DEVICE LaseMD and DUAL 1927nm Laser
- DEVICE LaseMD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-11-17 |
| Est. Completion | 2019-02-25 |
| Phase | NA |
What the finished NCT03409952 record still lists
NCT03409952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which LaseMD and DUAL 1927nm Laser is the first listed.
NCT03409952 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03409952 about?
NCT03409952 is a clinical study titled "Lutronic LaseMD for Treatment of Benign Pigmented Lesions". The Lutronic LaseMD Laser System will be evaluated for the treatment of benign pigmented lesions.
What is the current status of trial NCT03409952?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-11-17. Estimated completion is 2019-02-25.
What interventions are being tested in trial NCT03409952?
The interventions under investigation include: LaseMD and DUAL 1927nm Laser (DEVICE), LaseMD (DEVICE).
Who is sponsoring clinical trial NCT03409952?
This trial is sponsored by CynosureLutronic, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03409952's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI